Evidence map›Paper›PMID 42814320›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Natural Killer Cells and Innate Lymphoid Cells Immunoprofiling.

Christelle Piperoglou, Frédéric Vély

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Christelle PiperoglouAPHM, Hôpital de la Timone, Marseille Immunopole Profiling Platform, Marseille, France.
Frédéric VélyAPHM, Hôpital de la Timone, Marseille Immunopole Profiling Platform, Marseille, France. vely@ciml.univ-mrs.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenotyping of natural killer (NK) cells by flow cytometry allows a detailed analysis of their functional diversity and activation status. This multiparametric approach assesses the expression of activating or inhibitory receptors and detects markers of maturation or exhaustion. It is crucial for understanding the role of NK cells in the immune response, particularly against infections and tumor cells. This phenotyping also allows us to monitor the effects of immunomodulatory treatments and to identify prognostic or predictive biomarkers in different clinical contexts.

Indexed as

Flow CytometryImmunity, InnateImmunophenotypingKiller Cells, NaturalLymphocytesHumansFlow cytometryImmunoproflingNK cells

Identifiers

PMID42814320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.